Home » Topics » BioWorld Science

BioWorld Science
RSS

Rescriptor available through Canadian expanded access program

June 14, 1996

GS-840 enters phase II/III

June 14, 1996

The Liposome Company's Abelcet approved in Sweden

June 14, 1996

Sankyo reports anti-HIV-1 oligodeoxyribonucleotides

June 14, 1996

Outstanding efficiency of MBI-10 series compounds

June 14, 1996

SS Pharm. reveals antibacterial quinolones

June 14, 1996

Augmentin's new dosing/formulation cleared by FDA

June 14, 1996

Botulinum toxin type A as dermatology remedy

June 14, 1996

Positive phase III results for Phytopharm's Zemaphyte

June 14, 1996

Amgen reveals polypeptide KGF analogues

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...